U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Sat Jun 26 17:05:02 UTC 2021
Edited
by admin
on Sat Jun 26 17:05:02 UTC 2021
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
2S9ZZM9Q9V
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
BEVACIZUMAB, LICENSE HOLDER UNSPECIFIED
Preferred Name English
BEVACIZUMAB
EMA EPAR   INN   MART.   MI   USAN   VANDF   WHO-DD  
INN   USAN  
Official Name English
BEVACIZUMAB [INN]
Common Name English
BEVACIZUMAB [MART.]
Common Name English
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL RHUMAB-VEGF .GAMMA.-CHAIN ANTI-HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL RHUMAB-VEGF LIGHT CHAIN, DIMER
Common Name English
PF-06439535 [WHO-DD]
Common Name English
12-IGG1
Code English
RHUMAB-
Code English
R-435
Code English
BEVACIZUMAB [EMA EPAR]
Common Name English
BEVACIZUMAB [VANDF]
Common Name English
RG-435
Code English
BEVACIZUMAB [MI]
Common Name English
AVASTIN
Brand Name English
BEVACIZUMAB [PURPLE BOOK, CDER]
Common Name English
BEVACIZUMAB [WHO-DD]
Common Name English
BEVACIZUMAB [JAN]
Common Name English
BEVACIZUMAB [USAN]
Common Name English
USP MAB 002, MONOCLONAL IGG1 [USP-RS]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 291709
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
FDA ORPHAN DRUG 317810
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
FDA ORPHAN DRUG 294409
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
FDA ORPHAN DRUG 222906
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
FDA ORPHAN DRUG 619317
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
FDA ORPHAN DRUG 512215
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
FDA ORPHAN DRUG 193704
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
LIVERTOX 103
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
NDF-RT N0000178291
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
WHO-ATC L01XC07
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
NDF-RT N0000178292
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
EMA ASSESSMENT REPORTS AVASTIN (AUTHORIZED: OVARIAN NEOPLASMS)
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
WHO-VATC QL01XC07
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
FDA ORPHAN DRUG 318010
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
EMA ASSESSMENT REPORTS AVASTIN (AUTHORIZED: COLORECTAL NEOPLASMS)
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
EMA ASSESSMENT REPORTS AVASTIN (AUTHORIZED: CARCINOMA, RENAL CELL)
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
FDA ORPHAN DRUG 317510
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
NCI_THESAURUS C2496
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
FDA ORPHAN DRUG 505115
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
NDF-RT N0000193543
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
FDA ORPHAN DRUG 216405
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
NDF-RT N0000020007
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
NCI_THESAURUS C129822
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
FDA ORPHAN DRUG 172903
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
EU-Orphan Drug EU/3/14/1390
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
Code System Code Type Description
RXCUI
253337
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
PRIMARY RxNorm
LACTMED
Bevacizumab
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
PRIMARY
USP_CATALOG
1445547
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
PRIMARY USP-RS
CAS
216974-75-3
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
PRIMARY
INN
8017
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
PRIMARY
MERCK INDEX
M2464
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
PRIMARY Merck Index
WIKIPEDIA
BEVACIZUMAB
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
PRIMARY
FDA UNII
2S9ZZM9Q9V
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
PRIMARY
RXCUI
2268037
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
ALTERNATIVE
NCI_THESAURUS
C2039
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
PRIMARY
DRUG BANK
DB00112
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
PRIMARY
RXCUI
2046138
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
ALTERNATIVE
EVMPD
SUB16402MIG
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
PRIMARY
MESH
C469428
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
PRIMARY
DRUG CENTRAL
4956
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
PRIMARY
ChEMBL
CHEMBL1201583
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
PRIMARY
IUPHAR
6771
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
PRIMARY
HSDB
8080
Created by admin on Sat Jun 26 17:05:03 UTC 2021 , Edited by admin on Sat Jun 26 17:05:03 UTC 2021
PRIMARY
Related Record Type Details
BIOSIMILAR -> PARENT
TARGET -> AGONIST
BIOSIMILAR -> PARENT
SUB_CONCEPT->SUBSTANCE
SUB_CONCEPT->SUBSTANCE
TARGET -> INHIBITOR
SUB_CONCEPT->SUBSTANCE
SUB_CONCEPT->SUBSTANCE
SUB_CONCEPT->SUBSTANCE
BIOSIMILAR -> PARENT
SUB_CONCEPT->SUBSTANCE
SUB_CONCEPT->SUBSTANCE
SUB_CONCEPT->SUBSTANCE
SUB_CONCEPT->SUBSTANCE
BIOSIMILAR -> PARENT
SUB_CONCEPT->SUBSTANCE
BIOSIMILAR -> PARENT
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL